Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Lepu Biopharma Co., Ltd.
St. Jude Children's Research Hospital
Mayo Clinic
AstraZeneca
M.D. Anderson Cancer Center
Akeso
M.D. Anderson Cancer Center
Eisai Inc.
Mayo Clinic
Children's Oncology Group
Essen Biotech